| UniProt ID | CMIP_HUMAN | |
|---|---|---|
| UniProt AC | Q8IY22 | |
| Protein Name | C-Maf-inducing protein | |
| Gene Name | CMIP | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 773 | |
| Subcellular Localization | Nucleus . Cytoplasm . Isoform 2 is translocated to the nucleus and is specifically recruited during minimal change nephrotic syndrome (MCNS) (PubMed:12939343) (PubMed:15616553). Detected in nuclear and cytoplasmic compartments during MCNS relapse (Pu | |
| Protein Description | Plays a role in T-cell signaling pathway. Isoform 2 may play a role in T-helper 2 (Th2) signaling pathway and seems to represent the first proximal signaling protein that links T-cell receptor-mediated signal to the activation of c-Maf Th2 specific factor.. | |
| Protein Sequence | MDVTSSSGGGGDPRQIEETKPLLGGDVSAPEGTKMGAVPCRRALLLCNGMRYKLLQEGDIQVCVIRHPRTFLSKILTSKFLRRWEPHHLTLADNSLASATPTGYMENSVSYSAIEDVQLLSWENAPKYCLQLTIPGGTVLLQAANSYLRDQWFHSLQWKKKIYKYKKVLSNPSRWEVVLKEIRTLVDMALTSPLQDDSINQAPLEIVSKLLSENTNLTTQEHENIIVAIAPLLENNHPPPDLCEFFCKHCRERPRSMVVIEVFTPVVQRILKHNMDFGKCPRLRLFTQEYILALNELNAGMEVVKKFIQSMHGPTGHCPHPRVLPNLVAVCLAAIYSCYEEFINSRDNSPSLKEIRNGCQQPCDRKPTLPLRLLHPSPDLVSQEATLSEARLKSVVVASSEIHVEVERTSTAKPALTASAGNDSEPNLIDCLMVSPACSTMSIELGPQADRTLGCYVEILKLLSDYDDWRPSLASLLQPIPFPKEALAHEKFTKELKYVIQRFAEDPRQEVHSCLLSVRAGKDGWFQLYSPGGVACDDDGELFASMVHILMGSCYKTKKFLLSLAENKLGPCMLLALRGNQTMVEILCLMLEYNIIDNNDTQLQIISTLESTDVGKRMYEQLCDRQRELKELQRKGGPTRLTLPSKSTDADLARLLSSGSFGNLENLSLAFTNVTSACAEHLIKLPSLKQLNLWSTQFGDAGLRLLSEHLTMLQVLNLCETPVTDAGLLALSSMKSLCSLNMNSTKLSADTYEDLKAKLPNLKEVDVRYTEAW | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 7 | Phosphorylation | -MDVTSSSGGGGDPR -CCCCCCCCCCCCHH | 41.02 | 22210691 | |
| 8 (in isoform 2) | Phosphorylation | - | 40.49 | 24719451 | |
| 20 | Sumoylation | PRQIEETKPLLGGDV HHHHCCCCCCCCCCC | 36.63 | - | |
| 20 | Sumoylation | PRQIEETKPLLGGDV HHHHCCCCCCCCCCC | 36.63 | - | |
| 20 | Ubiquitination | PRQIEETKPLLGGDV HHHHCCCCCCCCCCC | 36.63 | - | |
| 20 (in isoform 1) | Ubiquitination | - | 36.63 | 21890473 | |
| 27 (in isoform 2) | Phosphorylation | - | 6.26 | 24719451 | |
| 34 | Ubiquitination | VSAPEGTKMGAVPCR CCCCCCCCCCCCCCH | 46.31 | - | |
| 73 | Phosphorylation | RHPRTFLSKILTSKF ECCHHHHHHHHHHHH | 17.29 | - | |
| 74 | Ubiquitination | HPRTFLSKILTSKFL CCHHHHHHHHHHHHH | 43.83 | 21890473 | |
| 74 (in isoform 1) | Ubiquitination | - | 43.83 | 21890473 | |
| 77 | Phosphorylation | TFLSKILTSKFLRRW HHHHHHHHHHHHHHC | 33.09 | - | |
| 78 | Phosphorylation | FLSKILTSKFLRRWE HHHHHHHHHHHHHCC | 20.26 | - | |
| 79 | Ubiquitination | LSKILTSKFLRRWEP HHHHHHHHHHHHCCC | 43.09 | 21890473 | |
| 79 (in isoform 1) | Ubiquitination | - | 43.09 | 21890473 | |
| 121 | Phosphorylation | IEDVQLLSWENAPKY HCCEEEECCCCCCCE | 40.72 | - | |
| 146 | Phosphorylation | VLLQAANSYLRDQWF HHHHHHHHHHHHHHH | 22.33 | - | |
| 147 | Phosphorylation | LLQAANSYLRDQWFH HHHHHHHHHHHHHHH | 12.93 | - | |
| 155 | Phosphorylation | LRDQWFHSLQWKKKI HHHHHHHHHHHHHHH | 16.87 | 20873877 | |
| 167 | Ubiquitination | KKIYKYKKVLSNPSR HHHHHHHHHHCCHHH | 45.37 | - | |
| 170 | Phosphorylation | YKYKKVLSNPSRWEV HHHHHHHCCHHHHHH | 50.08 | - | |
| 173 | Phosphorylation | KKVLSNPSRWEVVLK HHHHCCHHHHHHHHH | 55.03 | - | |
| 180 | Ubiquitination | SRWEVVLKEIRTLVD HHHHHHHHHHHHHHH | 39.21 | - | |
| 191 | Phosphorylation | TLVDMALTSPLQDDS HHHHHHHCCCCCCCC | 20.82 | 28270605 | |
| 192 | Phosphorylation | LVDMALTSPLQDDSI HHHHHHCCCCCCCCC | 25.18 | 28270605 | |
| 198 | Phosphorylation | TSPLQDDSINQAPLE CCCCCCCCCCHHHHH | 31.56 | 28270605 | |
| 211 (in isoform 3) | Ubiquitination | - | 7.49 | 21906983 | |
| 255 (in isoform 2) | Phosphorylation | - | 43.54 | 24719451 | |
| 256 | Phosphorylation | HCRERPRSMVVIEVF HHHHCCCCEEEEEEC | 20.72 | 28270605 | |
| 259 (in isoform 2) | Ubiquitination | - | 2.01 | 21906983 | |
| 272 | Ubiquitination | PVVQRILKHNMDFGK HHHHHHHHCCCCCCC | 30.48 | - | |
| 279 | Ubiquitination | KHNMDFGKCPRLRLF HCCCCCCCCCHHHHH | 40.85 | - | |
| 283 (in isoform 2) | Phosphorylation | - | 3.18 | 24719451 | |
| 337 | O-linked_Glycosylation | VCLAAIYSCYEEFIN HHHHHHHHHHHHHHH | 12.24 | 29485866 | |
| 349 | Phosphorylation | FINSRDNSPSLKEIR HHHCCCCCCCHHHHH | 21.83 | 22167270 | |
| 351 | Phosphorylation | NSRDNSPSLKEIRNG HCCCCCCCHHHHHCC | 52.47 | 22167270 | |
| 353 (in isoform 1) | Ubiquitination | - | 56.27 | 21890473 | |
| 353 | Ubiquitination | RDNSPSLKEIRNGCQ CCCCCCHHHHHCCCC | 56.27 | - | |
| 366 | Ubiquitination | CQQPCDRKPTLPLRL CCCCCCCCCCCCCCC | 29.15 | - | |
| 368 | Phosphorylation | QPCDRKPTLPLRLLH CCCCCCCCCCCCCCC | 44.00 | 23312004 | |
| 377 | Phosphorylation | PLRLLHPSPDLVSQE CCCCCCCCCCCCCCC | 21.94 | 29255136 | |
| 382 | Phosphorylation | HPSPDLVSQEATLSE CCCCCCCCCCCCCCH | 29.60 | 23403867 | |
| 386 | Phosphorylation | DLVSQEATLSEARLK CCCCCCCCCCHHHHH | 30.02 | 23403867 | |
| 388 | Phosphorylation | VSQEATLSEARLKSV CCCCCCCCHHHHHEE | 25.51 | 23403867 | |
| 409 | Phosphorylation | IHVEVERTSTAKPAL EEEEEEECCCCCCCE | 19.54 | - | |
| 410 | Phosphorylation | HVEVERTSTAKPALT EEEEEECCCCCCCEE | 32.37 | - | |
| 411 | Phosphorylation | VEVERTSTAKPALTA EEEEECCCCCCCEEC | 37.78 | - | |
| 419 | Phosphorylation | AKPALTASAGNDSEP CCCCEECCCCCCCCC | 31.32 | 28102081 | |
| 424 | Phosphorylation | TASAGNDSEPNLIDC ECCCCCCCCCCCHHH | 59.98 | 28348404 | |
| 435 | Phosphorylation | LIDCLMVSPACSTMS CHHHEEECCCCCEEE | 7.88 | 28102081 | |
| 439 | Phosphorylation | LMVSPACSTMSIELG EEECCCCCEEEEECC | 29.29 | 28102081 | |
| 440 | Phosphorylation | MVSPACSTMSIELGP EECCCCCEEEEECCC | 18.15 | 28102081 | |
| 442 | Phosphorylation | SPACSTMSIELGPQA CCCCCEEEEECCCCC | 17.01 | 28102081 | |
| 456 | Phosphorylation | ADRTLGCYVEILKLL CCHHHHHHHHHHHHH | 10.18 | 29396449 | |
| 491 | Ubiquitination | KEALAHEKFTKELKY HHHHHCHHHHHHHHH | 48.76 | - | |
| 593 (in isoform 2) | Phosphorylation | - | 14.01 | 24719451 | |
| 614 (in isoform 3) | Ubiquitination | - | 11.17 | 21906983 | |
| 645 | Phosphorylation | PTRLTLPSKSTDADL CCCEECCCCCCHHHH | 42.21 | 24719451 | |
| 646 | Ubiquitination | TRLTLPSKSTDADLA CCEECCCCCCHHHHH | 56.27 | - | |
| 647 | Phosphorylation | RLTLPSKSTDADLAR CEECCCCCCHHHHHH | 35.54 | - | |
| 648 | Phosphorylation | LTLPSKSTDADLARL EECCCCCCHHHHHHH | 38.65 | - | |
| 657 | Phosphorylation | ADLARLLSSGSFGNL HHHHHHHHCCCCCCC | 36.93 | 28060719 | |
| 658 | Phosphorylation | DLARLLSSGSFGNLE HHHHHHHCCCCCCCC | 38.12 | 28060719 | |
| 658 (in isoform 2) | Phosphorylation | - | 38.12 | 27642862 | |
| 660 | Phosphorylation | ARLLSSGSFGNLENL HHHHHCCCCCCCCHH | 31.74 | 28450419 | |
| 662 (in isoform 2) | Ubiquitination | - | 39.24 | 21906983 | |
| 668 | Phosphorylation | FGNLENLSLAFTNVT CCCCCHHHHHEECHH | 29.27 | 28060719 | |
| 672 | Phosphorylation | ENLSLAFTNVTSACA CHHHHHEECHHHHHH | 24.15 | 28060719 | |
| 687 | Phosphorylation | EHLIKLPSLKQLNLW HHHHCCCCHHHHCCC | 59.65 | 24719451 | |
| 707 | Phosphorylation | DAGLRLLSEHLTMLQ HHHHHHHHHHHHHHH | 27.80 | - | |
| 736 | Phosphorylation | LALSSMKSLCSLNMN HHHHHHHHHHCCCCC | 26.43 | - | |
| 739 | Phosphorylation | SSMKSLCSLNMNSTK HHHHHHHCCCCCCCC | 28.24 | - | |
| 746 | Ubiquitination | SLNMNSTKLSADTYE CCCCCCCCCCCCCHH | 40.02 | - | |
| 751 | Phosphorylation | STKLSADTYEDLKAK CCCCCCCCHHHHHHH | 28.64 | 28796482 | |
| 752 | Phosphorylation | TKLSADTYEDLKAKL CCCCCCCHHHHHHHC | 14.16 | 28796482 | |
| 756 (in isoform 1) | Ubiquitination | - | 56.66 | 21890473 | |
| 756 | Ubiquitination | ADTYEDLKAKLPNLK CCCHHHHHHHCCCCC | 56.66 | - | |
| 769 | Phosphorylation | LKEVDVRYTEAW--- CCCCCCCEECCC--- | 14.58 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CMIP_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CMIP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CMIP_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| FLNA_HUMAN | FLNA | physical | 15128042 | |
| P85A_HUMAN | PIK3R1 | physical | 20018188 | |
| MIB1_HUMAN | MIB1 | physical | 20018188 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-349, AND MASSSPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-377, AND MASSSPECTROMETRY. | |